Novartis AG
Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
Last updated:
Abstract:
The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
Status:
Grant
Type:
Utility
Filling date:
8 May 2018
Issue date:
18 Aug 2020